A phase II trial of rituximab as adjuvant to intensive sequential chemotherapy in patients under 60 years with untreated poor-prognosis diffuse large B-cell lymphoma.

Saved in:
Bibliographic Details
Title: A phase II trial of rituximab as adjuvant to intensive sequential chemotherapy in patients under 60 years with untreated poor-prognosis diffuse large B-cell lymphoma.
Authors: Coso, D.1, Sebban, C.2, Boulat, O.3, Biron, P.2, Rey, J.1, Aurran, T.1, Chabannon, C.1, Xerri, L.1, Chetaille, B.1, Esterni, B.1, Ivanov, V.1, Stoppa, A. M.1, Schiano de Collela, J. M.1, Gastaut, J. A.1, Maraninchi, D.1, Bouabdallah, R.1 bouabdr@marseille.fnclcc.fr
Source: Bone Marrow Transplantation. Aug2006, Vol. 38 Issue 3, p217-222. 6p. 1 Diagram, 3 Charts, 2 Graphs.
Database: Academic Search Ultimate
Description
ISSN:02683369
DOI:10.1038/sj.bmt.1705414